Drug and clinical candidate information for htr4 (ChEMBL ID: CHEMBL1875):

Molecule: TEGASEROD MALEATE
ChEMBL ID: CHEMBL1516474
Mechanism of Action: PARTIAL AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2002

Molecule: CISAPRIDE
ChEMBL ID: CHEMBL1729
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1993

Molecule: METOCLOPRAMIDE HYDROCHLORIDE
ChEMBL ID: CHEMBL1200940
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1979

Molecule: VELUSETRAG
ChEMBL ID: CHEMBL2087337
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: NARONAPRIDE
ChEMBL ID: CHEMBL2103858
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: REVEXEPRIDE
ChEMBL ID: CHEMBL3545035
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: CAPESEROD
ChEMBL ID: CHEMBL2027925
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PRUCALOPRIDE
ChEMBL ID: CHEMBL117287
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: CLEBOPRIDE
ChEMBL ID: CHEMBL325109
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: PRUCALOPRIDE SUCCINATE
ChEMBL ID: CHEMBL2105748
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 2009

Molecule: PRX-03140
ChEMBL ID: CHEMBL3306918
Mechanism of Action: PARTIAL AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: PIBOSEROD
ChEMBL ID: CHEMBL356359
Mechanism of Action: ANTAGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: FELCISETRAG
ChEMBL ID: CHEMBL2402904
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: RENZAPRIDE
ChEMBL ID: CHEMBL296522
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: LEVOSULPIRIDE
ChEMBL ID: CHEMBL267044
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule

Molecule: MOSAPRIDE
ChEMBL ID: CHEMBL60889
Mechanism of Action: AGONIST
Max Phase: 3.0
Molecule Type: Small molecule

Molecule: RELENOPRIDE
ChEMBL ID: CHEMBL3544975
Mechanism of Action: AGONIST
Max Phase: 2.0
Molecule Type: Small molecule
Drug and clinical candidate information for htr4 (ChEMBL ID: CHEMBL2096904):

Molecule: DEXFENFLURAMINE HYDROCHLORIDE
ChEMBL ID: CHEMBL1887891
Mechanism of Action: AGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: ZIMELDINE HYDROCHLORIDE
ChEMBL ID: CHEMBL2355333
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule

Molecule: AMISULPRIDE
ChEMBL ID: CHEMBL243712
Mechanism of Action: ANTAGONIST
Max Phase: 4.0
Molecule Type: Small molecule
First Approval: 1986
